Training for Urinary Incontinence After Pregnancy
(TULIP Trial)
Trial Summary
What is the purpose of this trial?
This is a multi-center, randomized single-blind nonsurgical trial conducted in approximately 216 primiparous postpartum women at high risk for prolonged/sustained pelvic floor disorders with symptomatic, bothersome urinary incontinence (UI) amenable to nonsurgical treatment. TULIP is a 3-Arm trial with two active interventions (Arms 1 and 2) and a Patient Education control arm (Arm 3). Arm 1 consists of pelvic floor muscle training (PFMT). Arm 2 uses a home biofeedback device (leva®). The primary outcome will be assessed at 6 months postpartum by blinded outcomes assessors, and follow-up will continue until 12 months postpartum.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of this treatment for urinary incontinence after pregnancy?
Is the leva device safe for use in humans?
How is the leva device treatment for urinary incontinence after pregnancy different from other treatments?
The leva device treatment is unique because it combines home pelvic floor exercises with a biofeedback device that guides users, making it easier to perform the exercises correctly and consistently. This approach helps overcome the common issue of low motivation in patients to continue pelvic floor muscle training on their own.156910
Research Team
David Rahn, MD
Principal Investigator
UTSW
Marie Gantz, PhD
Principal Investigator
RTI International
Eligibility Criteria
This trial is for new mothers who have just had their first child and are experiencing urinary incontinence. Participants should be at high risk for long-term pelvic floor disorders but able to undergo nonsurgical treatments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either interventionist-guided pelvic floor muscle training, home biofeedback device training, or education on pelvic floor muscle function
Follow-up
Participants are monitored for changes in urinary incontinence and other secondary outcomes
Extension
Continued monitoring and assessment of adherence to interventions and secondary outcomes
Treatment Details
Interventions
- Home pelvic floor exercises guided by the leva® device
- Interventionist-guided training
Home pelvic floor exercises guided by the leva® device is already approved in United States for the following indications:
- Stress urinary incontinence
- Urinary incontinence postpartum
Find a Clinic Near You
Who Is Running the Clinical Trial?
NICHD Pelvic Floor Disorders Network
Lead Sponsor
RTI International
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
University of Chicago
Collaborator
University of Pennsylvania
Collaborator
Duke University
Collaborator
Kaiser Permanente
Collaborator
University of California, San Diego
Collaborator
University of Texas Southwestern Medical Center
Collaborator
Women and Infants Hospital of Rhode Island
Collaborator